Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
RESEARCH TOOLSreports
Holding SUPN?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 175.69M | $ 168.32M | $ 143.64M | $ 153.88M | $ 135.56M |
| Gross Profit | $ 158.11M | $ 150.41M | $ 127.33M | $ 134.28M | $ 114.47M |
| EBIT | $ 44.94M | $ 26.30M | $ 243.00K | $ 9.89M | $ -16.46M |
| EBITDA | $ 65.05M | $ 47.02M | $ 20.99M | $ 31.75M | $ 4.26M |
| Net Income Common Stockholders | $ 38.50M | $ 19.92M | $ 124.00K | $ -15.98M | $ 79.00K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 403.21M | $ 347.19M | $ 297.74M | $ 200.19M | $ 151.66M |
| Total Assets | $ 1.34B | $ 1.32B | $ 1.30B | $ 1.29B | $ 1.29B |
| Total Debt | $ 28.93M | $ 30.29M | $ 32.99M | $ 33.84M | $ 34.18M |
| Net Debt | $ -374.28M | $ -316.89M | $ -264.74M | $ -166.35M | $ -117.48M |
| Total Liabilities | $ 335.55M | $ 358.38M | $ 374.92M | $ 372.97M | $ 373.19M |
| Stockholders Equity | $ 1.01B | $ 957.45M | $ 929.17M | $ 912.19M | $ 919.91M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 53.32M | $ 35.56M | $ 38.15M | $ 35.73M | $ -19.03M |
| Operating Cash Flow | $ 53.52M | $ 35.62M | $ 38.40M | $ 35.88M | $ -18.87M |
| Investing Cash Flow | $ -77.01M | $ -48.59M | $ -51.62M | $ 34.63M | $ 60.30M |
| Financing Cash Flow | $ 3.08M | $ 1.66M | $ 1.57M | $ -230.00K | $ -478.92M |